Asia Pacific Contrast Media Market Size

Asia Pacific Contrast Media Market Size

Asia Pacific Contrast Media Market By Product Type (Iodinated, Barium-based, Gadolinium-based and Microbubble) By Application (Neurological disorders, Cancer, Cardiovascular disorders, Gastrointestinal disorders, Nephrological disorders, Musculoskeletal disorders and Other Applications) By Modality (X-ray/CT, MRI and Ultrasound) By Country, Industry Analysis and Forecast, 2019 - 2025

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Published Date : March-2020 | Number of Pages : 96 | Format : PDF

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Contrast Media Market, by Product Type
1.4.2 Asia Pacific Contrast Media Market, by Application
1.4.3 Asia Pacific Contrast Media Market, by Modality
1.4.4 Asia Pacific Contrast Media Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : Sep, 2019–Mar, 2015) Leading Players

Chapter 4. Asia Pacific Contrast Media Market by Product Type
4.1 Asia Pacific Iodinated Market by Country
4.2 Asia Pacific Barium-based Market by Country
4.3 Asia Pacific Gadolinium-based Market by Country
4.4 Asia Pacific Microbubble Market by Country

Chapter 5. Asia Pacific Contrast Media Market by Application
5.1 Asia Pacific Neurological disorders Market by Country
5.2 Asia Pacific Cancer Market by Country
5.3 Asia Pacific Cardiovascular disorders Market by Country
5.4 Asia Pacific Gastrointestinal disorders Market by Country
5.5 Asia Pacific Nephrological disorders Market by Country
5.6 Asia Pacific Musculoskeletal disorders Market by Country
5.7 Asia Pacific Other Applications Market by Country

Chapter 6. Asia Pacific Contrast Media Market by Modality
6.1 Asia Pacific X-ray/CT Market by Country
6.2 Asia Pacific MRI Market by Country
6.3 Asia Pacific Ultrasound Market by Country

Chapter 7. Asia Pacific Contrast Media Market by Country
7.1 China Contrast Media Market
7.1.1 China Contrast Media Market by Product Type
7.1.2 China Contrast Media Market by Application
7.1.3 China Contrast Media Market by Modality
7.2 Japan Contrast Media Market
7.2.1 Japan Contrast Media Market by Product Type
7.2.2 Japan Contrast Media Market by Application
7.2.3 Japan Contrast Media Market by Modality
7.3 India Contrast Media Market
7.3.1 India Contrast Media Market by Product Type
7.3.2 India Contrast Media Market by Application
7.3.3 India Contrast Media Market by Modality
7.4 South Korea Contrast Media Market
7.4.1 South Korea Contrast Media Market by Product Type
7.4.2 South Korea Contrast Media Market by Application
7.4.3 South Korea Contrast Media Market by Modality
7.5 Singapore Contrast Media Market
7.5.1 Singapore Contrast Media Market by Product Type
7.5.2 Singapore Contrast Media Market by Application
7.5.3 Singapore Contrast Media Market by Modality
7.6 Malaysia Contrast Media Market
7.6.1 Malaysia Contrast Media Market by Product Type
7.6.2 Malaysia Contrast Media Market by Application
7.6.3 Malaysia Contrast Media Market by Modality
7.7 Rest of Asia Pacific Contrast Media Market
7.7.1 Rest of Asia Pacific Contrast Media Market by Product Type
7.7.2 Rest of Asia Pacific Contrast Media Market by Application
7.7.3 Rest of Asia Pacific Contrast Media Market by Modality

Chapter 8. Company Profiles
8.1 Bayer AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.5.2 Approvals:
8.2 General Electric (GE) Co. (GE Healthcare)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 The Guerbet Group
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.3.5.3 Product Launches and Product Expansions:
8.4 Lantheus Holdings, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.5 Bracco S.p.A.
8.5.1 Company Overview
8.5.2 Regional Analysis
8.5.3 Recent strategies and developments:
8.5.3.1 Product Launches and Product Expansions:
8.5.3.2 Acquisition and Mergers:
8.5.3.3 Approvals:
8.6 Trivitron Healthcare Pvt. Ltd.
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Partnerships, Collaborations, and Agreements:
8.7 Nano Therapeutics Pvt. Ltd.
8.7.1 Company Overview
8.8 Magnus Health, LLC (Veracross LLC)
8.8.1 Company Overview
8.9 Imax Diagnostic Imaging Limited
8.9.1 Company Overview
8.1 Daiichi Sankyo Company, Limited
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:


Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities